Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

RAB17, Member RAS Oncogene Family (RAB17) antibody

Antigen

RAB17, Member RAS Oncogene Family (RAB17)

Synonyms FLJ12538, AW413472, RGD1562478, RAB17
Clonality Polyclonal
Host
Reactivity
Alternatives

Mouse (Murine)

Application
Alternatives ELISA, Western Blotting (WB)
1 reference available
Catalog no. ABIN334472
Quantity 100 ug
Price 501.80 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name Rab17 (mouse)
Gene ID 19329 (mouse), 503269 (rat)
Immunogen C-RKDSFHKAQQWLED
Description All names and symbols: RAB17, RAB17, member RAS oncogene family , AW413472. Official Symbol: Rab17. RefSeq number(s): NP_033024.1
Specificity Mouse, Rat

Application Details

Application Notes Peptide ELISA: antibody detection limit dilution 1:64,000. Western Blot: Approx 23kDa band observed in Mouse Kidney lysates (calculated MW of 23.6kDa according to NP_033024.1). Recommended concentration: 0.2-0.6µg/ml.
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Buffer Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Storage Aliquot and store at -20°C. Minimize freezing and thawing.
Restrictions For Research Use only

Publications

Publications Yoshimura, Egerer, Fuchs et al.: "Functional dissection of Rab GTPases involved in primary cilium formation." in: The Journal of cell biology, Vol. 178, Issue 3, pp. 363-9, 2007 (PubMed).

Alternatives

Alternatives for antigen "RAB17, Member RAS Oncogene Family (RAB17)", type "Antibodies"
Hosts Mouse (9), Goat (2), Rabbit (1)
Reactivities Human (10), Mouse (Murine) (2), Rat (Rattus) (1)
Applications Western Blotting (WB) (8), ELISA (3), Enzyme Immunoassay (EIA) (3), Immunofluorescence (IF) (3), Immunohistochemistry (IHC) (3), ELISA (Detection) (2), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (2)
Epitopes transcript variant 1 (3)